Riskpilot← Back to searchSign inGet full accessLevel Bio AB (publ)
ABActiveOrg 5565554382Fannys Väg 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 19981 employees
Revenue 2024
SEK 1,4M
+539% vs 2023
EBITDA margin
-178.8%
+13% vs 2023
Equity ratio
75.7%
Financial strength
Net profit 2024
SEK -5,6M
+28% vs 2023
| Revenue | SEK 1,4M | +539% |
| EBITDA | SEK -2,6M | +13% |
| Net profit | SEK -5,6M | +28% |
| Total assets | SEK 21,1M | +1% |
| Equity | SEK 16M | -20% |
| Employees | 1 | — |
Legal name
Level Bio AB (publ)
Org number
5565554382
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
16 juni 1998
Share capital
SEK 741 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Föremålet för bolagets verksamhet är att i egen regi eller genom dotterbolag 1. utveckla, tillverka och marknadsföra instrument, förbrukningsartiklar och konsulttjänster inom området molekylär- biologi, 2. utveckla, tillverka och marknadsföra högteknologiprodukter med anknytning och avsättning till naturvetenskaplig forskning och industriell mät-, kontroll- och reglerteknik, 3. bedriva agenturverksamhet med produkter inriktade på behoven hos målgruppen definierad under punkten 2 ovan, samt 4. bedriva därmed förenlig verksamhet.
Address
Fannys Väg 5
Email
info@levelbio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 200 | 250 | 300 | 225 | 1 437 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −771 | −462 | −401 | −2 963 | −2 570 |
| Depreciation & amort. | −0 | −0 | −22 | −43 | −43 |
| EBIT | −771 | −462 | −423 | −3 006 | −2 613 |
| Net financials | — | — | −42 | 1 | −18 |
| Profit before tax | 1 489 | 6 186 | −356 | −7 875 | −5 616 |
| Tax | −0 | −167 | −0 | −0 | −30 |
| Net profit | 1 489 | 6 019 | −356 | −7 875 | −5 646 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 441 | 28 456 | 28 088 | 20 920 | 21 075 |
| Equity | 8 225 | 28 203 | 27 848 | 19 972 | 15 960 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 216 | 252 | 240 | 947 | 5 115 |
| Total debt | 216 | 252 | 240 | 947 | 5 115 |
EBITDA margin
-178.8%
This company
15.8%
Market median
-1232% vs market
20202024
Equity ratio
75.7%
This company
38.2%
Market median
+98% vs market
20202024
Return on equity
-35.4%
This company
18.4%
Market median
-292% vs market
20202024
Net profit margin
-392.9%
This company
8.1%
Market median
-4951% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ÅA Chief Auditor | Chief Auditor | 2020 |
PJ Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
MU Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Chairman | 2024 | |
| Board of Directors | 2020 | |
| Board of Directors | 2024 | |
| Board of Directors | 2020 | |
| Board of Directors | 2022 | |
| Board of Directors | 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Level Bio AB (publ) (this company)
CyberGene AktiebolagBoard members of Level Bio AB (publ) also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsa Anita Dahlgren | Chief Auditor | 0 companies |
| Per Joakim Grånemo | Chief Executive Officer | 0 companies |
| Mattias Ulf Mir Molin | Chief Executive Officer | 0 companies |
| Artur Bernardino Aira | Chairman | 0 companies |
| Johan Anders Mikael Havsjö | Board of Directors | 0 companies |
| Mikael Kubista | Board of Directors | 0 companies |
| Anita Maria Ulrica Karlsson | Board of Directors | 0 companies |
| Johan Tobias Schön | Board of Directors | 0 companies |
| Neven Zoric | Board of Directors | 0 companies |